ARCTURUS THERAPEUTICS HOLDIN (ARCT) Stock Income Statement
USA - NASDAQ:ARCT - US03969T1097 - Common Stock
20.46 USD
+0.84 (+4.28%)
20.64 USD
+0.18 (+0.88%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 122.12M | 152.31M | 166.80M | 206.00M | 12.40M | |||
| Operating Expenses | 194.69M | 247.98M | 245.00M | 193.80M | 215.20M | |||
| Research and Development | 147.39M | 195.16M | 192.13M | 147.80M | 173.80M | |||
| Selling, General, and Administrative Expenses | 47.31M | 52.82M | 52.87M | 46.10M | 41.50M | |||
| Operating Income | -72.57M | -95.67M | -78.20M | 12.20M | -202.90M | |||
| Interest Income/Expense | 12.19M | 14.72M | 16.36M | -1.50M | -800.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | 33.95M | N/A | N/A | |||
| Income Before Taxes | -60.38M | -80.94M | -27.89M | 10.60M | -203.70M | |||
| Income Tax | -217.00K | -4.00K | 1.83M | 1.30M | N/A | |||
| Net Income | -60.16M | -80.94M | -29.73M | 9.30M | -203.70M | |||
| EBITDA | -69.26M | -92.13M | -75.25M | 13.73M | -201.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.22 | -3.00 | -1.12 | 0.35 | -7.74 | |||
| Non GAAP EPS | -2.23 | -3.01 | -1.04 | 0.34 | -7.74 | |||
| Statistics | ||||||||
| Profit Margin | -49.27% | -53.14% | -17.82% | 4.51% | -1642.74% | |||
| Operating Profit Margin | -59.43% | -62.81% | -46.89% | 5.92% | -1636.29% | |||
All data in USD